357 Results (Page 2 of 15)
Singapore Markets Research Reports
Singapore Orphan Diseases Drugs Market Analysis
This report presents a strategic analysis of the Singapore Orphan Diseases Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Singapore Orphan Diseases Drugs Market, offering unmatched value, accuracy and expert insights.
Singapore Electronic Health Records Market Analysis
Singapore's Electronic Health Record (EHR) market size was valued at $xx Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Bn in 2030. Singapore's EHR market growth is due to government initiatives to promote the use of EHR systems and increasing demand for cost-effective and efficient healthcare services. The market is segmented, by application type, and end user. The key market players are MIMS, Allscripts, Cerner, Epic Systems, and others.
Singapore Digital Therapeutics Market Analysis
Singapore Digital Therapeutics Market is at around $7 Mn in 2023 and is projected to reach $38.98 Mn in 2030, exhibiting a CAGR of 27.8 % during the forecast period. The market is being driven by rising chronic disease burden, healthcare infrastructure, and government initiatives and support. The market is dominated by key players like BioMind Labs, DoctorOnCall, FitBit Health Solutions, Omada Health Inc., 2Morrow Inc., Livongo Health Inc., WellDoc, Propeller Health, Canary Health, and Noom Inc.
Singapore Artificial Intelligence (AI) in Healthcare Market Analysis
The Singapore Artificial Intelligence (AI) In Healthcare Market is projected to grow from $0.01 Bn in 2022 to $0.17 Bn by 2030, registering a CAGR of 45.82% during the forecast period of 2022 - 2030. The market will be driven by the need for improved efficiency, quality, and accessibility of healthcare services along with Singapore’s thriving startup ecosystem. The market is segmented by healthcare components & by healthcare applications. Some of the major players include NVIDIA, Ping An Healthcare and Technology & CoNEX Healthcare Pte Ltd.
Singapore Biomaterials in Healthcare Market Analysis
Singapore Biomaterials in Healthcare Market is expected to witness growth from $188 Mn in 2022 to $527 Mn in 2030 with a CAGR of 13.80% for the forecasted year 2022-2030. Tissue engineering and other regenerative therapies that depend on biomaterials are becoming more widely known and used in Singapore, which has led to an expansion of the country's Biomaterials in the Healthcare market. The market is segmented by type and by application. Some key players in this market include Biosensors International, Everlife, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.
Singapore Medical Devices Market Analysis
This report presents a strategic analysis of the Singapore Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Singapore Medical Devices Market, offering unmatched value, accuracy and expert insights.
Singapore Dermatological Therapeutics Market Analysis
Singapore Dermatological Therapeutics Market is at around $0.05 Bn in 2023 and is projected to reach $0.09 Bn in 2030, exhibiting a CAGR of 9.2% during the forecast period. The market is expanding as a result of the prevalence of skin conditions, rising awareness, and consumer preferences for aesthetic procedures. The market is dominated by key players like Almirall SA, Pfizer Inc., GlaxoSmithKline Plc, AbbVie Inc., Amgen Inc., Novartis AG, Roche, Sanofi, Bayer, and Johnson & Johnson.
Singapore Blockchain Technology in Healthcare Market Analysis
This report presents a strategic analysis of Singapore Blockchain Technology in the Healthcare Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about Singapore Blockchain Technology in the Healthcare Market, offering unmatched value, accuracy and expert insights.
Singapore Medical and Diagnostic Laboratory Service Market Analysis
This report presents a strategic analysis of the Singapore Medical and Diagnostic Laboratory Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Singapore Medical and Diagnostic Laboratory Service Market, offering unmatched value, accuracy and expert insights.
Singapore Healthcare Diagnostics Market Analysis
This report presents a strategic analysis of the Singapore Healthcare Diagnostics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Singapore Healthcare Diagnostics Market, offering unmatched value, accuracy and expert insights.
Singapore Patient Support Programs (PSP) Market Analysis
This report presents a strategic analysis of the Singapore Patient Support Programs (PSP) Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Singapore Patient Support Programs (PSP) Market, offering unmatched value, accuracy and expert insights.
Singapore Cholesterol Therapeutics Market Analysis
The Singapore Cholesterol Therapeutics Market is anticipated to experience a growth from $29 Mn in 2022 to $38 Mn by 2030, with a CAGR of 3.2 % during the forecast period of 2022-2030. The key drivers of the market include the rising prevalence of abnormal cholesterol and CVDs due to unhealthy lifestyles, coupled with increased government initiatives investing in healthcare, awareness campaigns, and screening programs, further fueled by a growing public awareness and proactive approach towards preventive healthcare. The Singapore Cholesterol Therapeutics Market encompasses various players across different segments such as AbbVie, Amgen, AstraZeneca, Pfizer, Mylan, Teva, Apotex, Biocon, Cipla, Dr Reddy’s, etc., among various others.
Singapore Pain Management Devices Market Analysis
This report presents a strategic analysis of the Singapore Pain Management Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Singapore Pain Management Devices Market, offering unmatched value, accuracy and expert insights.
Singapore Virtual Clinical Trials Market Analysis
This report presents a strategic analysis of the Singapore Virtual Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Singapore Virtual Clinical Trials Market, offering unmatched value, accuracy, and expert insights.
Singapore Alzheimer’s Therapeutics Market Analysis
Singapore alzheimer’s therapeutics market valued at $6 Mn in 2022, projected to reach $12 Mn by 2030 with a 9.7% CAGR. The market for medications used to treat Alzheimer's disease is mostly driven by the condition's increasing prevalence, which is fuelled by an aging population. The top pharmaceutical firms in the industry currently operating in the market are Eisai, Biogen, GlaxoSmithKline, Novartis, Pfizer, Roche, Johnson & Johnson, Eli Lilly, AstraZeneca and Merck & Co.
Singapore Infectious Disease Drugs Market Analysis
Singapore Infectious Disease Drugs Market valued at $0.14 Bn in 2023, projected to reach $0.20 Bn by 2030 with a 4.87% CAGR. The market is growing due to the rising prevalence of infectious diseases, the emphasis on research and development, and the adoption of antiviral therapies. The market is dominated by key players like Temasek Life Sciences Laboratory, Acumen Research Laboratories, AbbVie Inc., Gilead Sciences, Merck & Co., F. Hoffman-La Roche Ltd., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, and Novartis AG.
Singapore Atopic Dermatitis Therapeutics Market Analysis
The Singapore Atopic Dermatitis Therapeutics Market was valued at US $15 Mn in 2022, and is predicted to grow at (CAGR) of 9.4% from 2023 to 2030, to US $30 Mn by 2030. The key drivers of this industry include the increased burden of Atopic Dermatitis (AD), strong healthcare infrastructure, supportive government policies, and others. The industry is primarily dominated by players such as Sanofi, Galderma, Merck, AbbVie, Glenmark, Novartis, and Johnson & Johnson, among others.
Singapore Atherosclerosis Therapeutics Market Analysis
Singapore Atherosclerosis Therapeutics Market was valued at $3 Mn in 2022 and is estimated to reach $5 Mn in 2030, exhibiting a CAGR of 6.3% during the forecast period. The increasing number of cardiovascular disease cases, which are exacerbated by poor dietary habits, sedentary lifestyles, and an aging global population, is predicted to drive up demand for atherosclerosis treatments. The top leading pharmaceutical companies presently operating in the industry are Pfizer, Novartis, AstraZeneca, Sanofi, Bayer, Abbott Laboratories, Eli Lilly, Eisai, Takeda and Mitsubishi Tanabe Pharma Corporation.
Singapore Asthma and COPD Therapeutics Market Analysis
The Singapore Asthma and COPD Therapeutics Market was valued at US $40 Mn in 2022, and is predicted to grow at (CAGR) of 5.80% from 2023 to 2030, to US $63 Mn by 2030. The key drivers of this industry include the rise in the prevalence of COPD and asthma, growth in disposable income, increased awareness, and others. The industry is primarily dominated by players such as AstraZeneca, Teva, Novartis, GlaxoSmithKline, and Boehringer Ingelheim, among others.
Singapore HIV Drugs Market Analysis
Singapore HIV Drugs Market is at around $38.04 Mn in 2023 and is projected to reach $50.74 Mn in 2030, exhibiting a CAGR of 4.2% during the forecast period. The market is being driven by developments in drug research, government initiatives, and the rising prevalence of HIV. The market is dominated by key players like Aslan Pharmaceuticals, Gilead Sciences, ViiV Healthcare, Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Merck & Co., Bristol-Myers Squibb, AbbVie Inc., F. Hoffmann-La Roche Ltd., and Novartis.
Singapore Antifungal Drugs Market Analysis
Singapore Antifungal Drugs Market is at around $0.019 Bn in 2023 and is projected to reach $0.026 Bn in 2030, exhibiting a CAGR of 4.4% during the forecast period. The market is expanding due to rising awareness and education, advancements in healthcare infrastructure, and an increase in the incidence of fungal infections. The market is dominated by key players like Pfizer Inc., Merck & Co., Novartis AG, Abbott Laboratories, Astellas Pharma Inc., GlaxoSmithKline plc, Bayer AG, Glenmark Pharmaceuticals Limited, Sanofi S.A., and Gilead Sciences Inc.
Singapore Cartilage Repair/Regeneration Market Analysis
Singapore Cartilage Repair/Regeneration Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The global cartilage repair market is expanding rapidly because to an ageing population, rising obesity, rising healthcare spending, and an increase in sports-related injuries. Furthermore, a surge in innovative product introductions and the growth of medical tourism, which is raising awareness about cartilage treatment modalities around the world, is fueling market growth. Zimmer Biomet Holdings, Inc., Smith & Nephew plc, Arthrex, Stryker Corporation, Medtronic plc, Vericel Corporation, CONMED Corporation, Anika Therapeutics, Osiris Therapeutics, Misonix, BioTissue Technologies GmbH, Histogenics Corporation, RTI Surgical Holdings, Collagen Solutions Plc, Orthocell Limited are some of the global key players in Cartilage Repair/Regeneration Market.
Singapore Cell Based Immunotherapy Market Analysis
Singapore Cell Based Immunotherapy Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing incidence of cancer, advancements in cell therapy technologies, a favourable regulatory environment, growing investments and collaborations, the trend toward personalised medicine, positive clinical outcomes, and patient demand for effective and targeted treatments are driving the cell-based immunotherapy market. Novartis, Gilead Sciences, Bristol Myers Squibb, bluebird bio, Adaptimmune Therapeutics, Cellectis, and Precision Biosciences are among the leading global players.
Singapore Cholesterol / Lipid Lowering Drugs Market Analysis
Singapore Cholesterol / Lipid Lowering Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising global prevalence of cardiovascular diseases, increased awareness about the health risks associated with high cholesterol levels, the ageing population, sedentary lifestyles, unhealthy dietary habits, and the need for effective treatments are some of the key drivers in the cholesterol/lipid lowering drugs market. growth. Sanofi, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., AbbVie, Inc., Viatris (Mylan N.V.), AstraZeneca PLC, and Dr. Reddy�s Laboratories Ltd.are global key players in Cholesterol / Lipid Lowering Drugs Market.
Singapore Chondroitin Market Analysis
Singapore Chondroitin Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for chondroitin is driven by factors such as the increasing prevalence of musculoskeletal disorders and osteoarthritis, the growing aging population, rising consumer awareness about the benefits of natural and alternative therapies, and the demand for effective and safe solutions for joint health. Synutra Pure Ltd., TSI Group Ltd. Bioiberica S.A.U., Seikagaku Corporation, etc. are some of the global companies in this market.